ALLInBio

ALLInBio is a biotechnology company developing a precision immunology approach to treat chronic inflammatory diseases. The company aims to shift patient care from managing symptoms to addressing the root cause by identifying and treating genetically predisposed 'at-risk' populations early. Its focus is on enabling selection of patients likely to progress to severe disease for targeted intervention.